Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GMAFX vs. QLTY: which is better?

Bottom line

GMAFX vs QLTY: the short answer

GMAFX (GMO Emerging Country Debt Shares Fund) and QLTY (GMO U.S. Quality ETF) are both mutual funds.

But QLTY is far broader, holding 42 positions to 2 for GMAFX, so beyond the top names it adds exposure GMAFX doesn't have.

QLTY is cheaper at 0.5% vs 0.67% — a difference of $17 a year per $10,000 invested.

Over one year, QLTY returned +21.1% vs +20.5% for GMAFX.

Updated Nov 19, 2026

GMAFX vs QLTY side by side

GMAFXQLTY
TypeMutual fundETF
Fund familyGmoGmo
CategoryEmerging MarketsLarge Blend
Expense ratio0.67%0.5%
Annual cost per $10k$67$50
10-yr cost on $10k (prospectus)—$628
Max front load—None
12b-1 fee—0%
1-yr return+20.5%+21.1%
5-yr return (annualized)+5.8%—
10-yr return (annualized)+7.0%—
Best quarter—+11.8%
Worst quarter—−2.2%
Net assets (fund)$61.8M$4.5B
Number of holdings242
Portfolio turnover%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GMAFX and QLTY share none of their top holdings.

GMAFX top 10

  1. GMO Emerging Country Debt — 100.04%
  2. State Street Global Advisors — 0.03%

QLTY top 10

  1. Microsoft Corp — 7.17%
  2. Alphabet Inc — 5.64%
  3. Lam Research Corp — 5.38%
  4. Apple Inc — 5.12%
  5. Broadcom Inc — 4.79%
  6. Texas Instruments Inc — 4.44%
  7. Meta Platforms Inc — 4.31%
  8. Johnson & Johnson — 4.22%
  9. KLA Corp — 3.98%
  10. Amazon.com Inc — 3.90%

FAQ

What is the difference between GMAFX and QLTY?
GMAFX (GMO Emerging Country Debt Shares Fund) and QLTY (GMO U.S. Quality ETF) are both mutual funds. But QLTY is far broader, holding 42 positions to 2 for GMAFX, so beyond the top names it adds exposure GMAFX doesn't have.
Which is cheaper, GMAFX or QLTY?
QLTY has the lower expense ratio (0.5%).
Should I own both GMAFX and QLTY?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.